z-logo
open-access-imgOpen Access
Network pharmacology‑based study to explore the mechanism of the Yiqi Gubiao pill in lung cancer treatment
Author(s) -
Zheng Li,
Dan Xu,
Jing Jing,
Fengsen Li
Publication year - 2021
Publication title -
oncology letters
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.766
H-Index - 54
eISSN - 1792-1082
pISSN - 1792-1074
DOI - 10.3892/ol.2021.12583
Subject(s) - akt1 , pill , pi3k/akt/mtor pathway , protein kinase b , kegg , pharmacology , biology , oncogene , cancer , signal transduction , medicine , cell cycle , gene , gene expression , gene ontology , microbiology and biotechnology , genetics

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom